Lawrence A. Yannuzzi, MD
Manhattan Eye, Ear & Throat Hospital
6
6
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Richard Kaufman, MD
Brigham and Women's Hospital
Shared therapeutic areas:
Catherine A Cukras, M.D.
National Eye Institute (NEI)
Shared therapeutic areas:
Cavan Reilly, PhD
University of Minnesota
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Thuy Doan, MD, PhD
University of California, San Francisco
Shared therapeutic areas:
Benoît Lamarche, PhD
Laval University
Shared therapeutic areas:
Jeffrey S Heier, MD
Ophthalmic Consultants of Boston
Shared therapeutic areas:
Stefania Basili, MD
University of Roma La Sapienza
Shared therapeutic areas:
Stephen Luby, MD
Stanford University
Shared therapeutic areas:
Pablo Velazquez-Martin, MD
Kodiak Sciences Inc
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
All 6 trials loaded